• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVAN:MM

699.13 MXN 20.87 2.90%

As of 16:09:04 ET on 10/21/2014.

Snapshot for Teva Pharmaceutical Industries Ltd (TEVAN)

Open: 699.13 Day's Range: 699.13 - 699.13 Volume: 1,995
Previous Close: 720.00 52wk Range: 490.00 - 720.00 1-Yr Rtn: -

Stock Chart for TEVAN

No chart data available.
  • TEVAN:MM 699.13
  • 1D
  • 1M
  • 1Y
720.00
Interactive TEVAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEVAN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 10.5704
Relative P/E vs. MEXBOL -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 4.8850
Est. PEG Ratio 4.0176
Market Cap (M MXN) 597,057.02
Shares Outstanding (M) 854.00
30 Day Average Volume 96
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.56%
Cash Dividend (USD) 0.2911
Dividend Ex-Date 08/19/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEVAN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEVAN

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOItzhak KrinskyChairman:Teva Japan & South Korea
Allan ObermanPresident & CEO:AmericasJudith VardiPresident & CEO:Emia & Asia Pacific
More Company Profile & Key Executives for TEVAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil